Global Erectile Dysfunction Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 100514
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Erectile Dysfunction market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Erectile Dysfunction market size is estimated to be worth US$ 4995.6 million in 2021 and is forecast to a readjusted size of USD 7328.5 million by 2028 with a CAGR of 5.6% during review period. Congenital Patients accounting for % of the Erectile Dysfunction global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ED Drugs segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Erectile Dysfunction include Eli Lilly, Pfizer, Bayer, Boston Scientific, and Coloplast, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Erectile Dysfunction market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

ED Drugs

ED Devices

Market segment by Application, can be divided into

Congenital Patients

Pathological Patients

Market segment by players, this report covers

Eli Lilly

Pfizer

Bayer

Boston Scientific

Coloplast

Apricus Biosciences

Cristalia Produtos Quimicos Farmaceuticos

Dong-A Socio

Endo Pharmaceuticals

Futura Medical

Meda Pharmaceuticals

Promedon

SK Chemical

Teva Pharmaceuticals

Vivus

Zephyr Surgical Implants (ZSI)

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Erectile Dysfunction product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Erectile Dysfunction, with revenue, gross margin and global market share of Erectile Dysfunction from 2019 to 2022.

Chapter 3, the Erectile Dysfunction competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Erectile Dysfunction market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Erectile Dysfunction research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Erectile Dysfunction

1.2 Classification of Erectile Dysfunction by Type

1.2.1 Overview: Global Erectile Dysfunction Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Erectile Dysfunction Revenue Market Share by Type in 2021

1.2.3 ED Drugs

1.2.4 ED Devices

1.3 Global Erectile Dysfunction Market by Application

1.3.1 Overview: Global Erectile Dysfunction Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Congenital Patients

1.3.3 Pathological Patients

1.4 Global Erectile Dysfunction Market Size & Forecast

1.5 Global Erectile Dysfunction Market Size and Forecast by Region

1.5.1 Global Erectile Dysfunction Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Erectile Dysfunction Market Size by Region, (2017-2022)

1.5.3 North America Erectile Dysfunction Market Size and Prospect (2017-2028)

1.5.4 Europe Erectile Dysfunction Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Erectile Dysfunction Market Size and Prospect (2017-2028)

1.5.6 South America Erectile Dysfunction Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Erectile Dysfunction Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Erectile Dysfunction Market Drivers

1.6.2 Erectile Dysfunction Market Restraints

1.6.3 Erectile Dysfunction Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Eli Lilly

2.1.1 Eli Lilly Details

2.1.2 Eli Lilly Major Business

2.1.3 Eli Lilly Erectile Dysfunction Product and Solutions

2.1.4 Eli Lilly Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Eli Lilly Recent Developments and Future Plans

2.2 Pfizer

2.2.1 Pfizer Details

2.2.2 Pfizer Major Business

2.2.3 Pfizer Erectile Dysfunction Product and Solutions

2.2.4 Pfizer Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Pfizer Recent Developments and Future Plans

2.3 Bayer

2.3.1 Bayer Details

2.3.2 Bayer Major Business

2.3.3 Bayer Erectile Dysfunction Product and Solutions

2.3.4 Bayer Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Bayer Recent Developments and Future Plans

2.4 Boston Scientific

2.4.1 Boston Scientific Details

2.4.2 Boston Scientific Major Business

2.4.3 Boston Scientific Erectile Dysfunction Product and Solutions

2.4.4 Boston Scientific Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Boston Scientific Recent Developments and Future Plans

2.5 Coloplast

2.5.1 Coloplast Details

2.5.2 Coloplast Major Business

2.5.3 Coloplast Erectile Dysfunction Product and Solutions

2.5.4 Coloplast Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Coloplast Recent Developments and Future Plans

2.6 Apricus Biosciences

2.6.1 Apricus Biosciences Details

2.6.2 Apricus Biosciences Major Business

2.6.3 Apricus Biosciences Erectile Dysfunction Product and Solutions

2.6.4 Apricus Biosciences Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Apricus Biosciences Recent Developments and Future Plans

2.7 Cristalia Produtos Quimicos Farmaceuticos

2.7.1 Cristalia Produtos Quimicos Farmaceuticos Details

2.7.2 Cristalia Produtos Quimicos Farmaceuticos Major Business

2.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Product and Solutions

2.7.4 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Developments and Future Plans

2.8 Dong-A Socio

2.8.1 Dong-A Socio Details

2.8.2 Dong-A Socio Major Business

2.8.3 Dong-A Socio Erectile Dysfunction Product and Solutions

2.8.4 Dong-A Socio Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Dong-A Socio Recent Developments and Future Plans

2.9 Endo Pharmaceuticals

2.9.1 Endo Pharmaceuticals Details

2.9.2 Endo Pharmaceuticals Major Business

2.9.3 Endo Pharmaceuticals Erectile Dysfunction Product and Solutions

2.9.4 Endo Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Endo Pharmaceuticals Recent Developments and Future Plans

2.10 Futura Medical

2.10.1 Futura Medical Details

2.10.2 Futura Medical Major Business

2.10.3 Futura Medical Erectile Dysfunction Product and Solutions

2.10.4 Futura Medical Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Futura Medical Recent Developments and Future Plans

2.11 Meda Pharmaceuticals

2.11.1 Meda Pharmaceuticals Details

2.11.2 Meda Pharmaceuticals Major Business

2.11.3 Meda Pharmaceuticals Erectile Dysfunction Product and Solutions

2.11.4 Meda Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Meda Pharmaceuticals Recent Developments and Future Plans

2.12 Promedon

2.12.1 Promedon Details

2.12.2 Promedon Major Business

2.12.3 Promedon Erectile Dysfunction Product and Solutions

2.12.4 Promedon Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Promedon Recent Developments and Future Plans

2.13 SK Chemical

2.13.1 SK Chemical Details

2.13.2 SK Chemical Major Business

2.13.3 SK Chemical Erectile Dysfunction Product and Solutions

2.13.4 SK Chemical Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 SK Chemical Recent Developments and Future Plans

2.14 Teva Pharmaceuticals

2.14.1 Teva Pharmaceuticals Details

2.14.2 Teva Pharmaceuticals Major Business

2.14.3 Teva Pharmaceuticals Erectile Dysfunction Product and Solutions

2.14.4 Teva Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Teva Pharmaceuticals Recent Developments and Future Plans

2.15 Vivus

2.15.1 Vivus Details

2.15.2 Vivus Major Business

2.15.3 Vivus Erectile Dysfunction Product and Solutions

2.15.4 Vivus Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Vivus Recent Developments and Future Plans

2.16 Zephyr Surgical Implants (ZSI)

2.16.1 Zephyr Surgical Implants (ZSI) Details

2.16.2 Zephyr Surgical Implants (ZSI) Major Business

2.16.3 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Product and Solutions

2.16.4 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Zephyr Surgical Implants (ZSI) Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Erectile Dysfunction Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Erectile Dysfunction Players Market Share in 2021

3.2.2 Top 10 Erectile Dysfunction Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Erectile Dysfunction Players Head Office, Products and Services Provided

3.4 Erectile Dysfunction Mergers & Acquisitions

3.5 Erectile Dysfunction New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Erectile Dysfunction Revenue and Market Share by Type (2017-2022)

4.2 Global Erectile Dysfunction Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Erectile Dysfunction Revenue Market Share by Application (2017-2022)

5.2 Global Erectile Dysfunction Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Erectile Dysfunction Revenue by Type (2017-2028)

6.2 North America Erectile Dysfunction Revenue by Application (2017-2028)

6.3 North America Erectile Dysfunction Market Size by Country

6.3.1 North America Erectile Dysfunction Revenue by Country (2017-2028)

6.3.2 United States Erectile Dysfunction Market Size and Forecast (2017-2028)

6.3.3 Canada Erectile Dysfunction Market Size and Forecast (2017-2028)

6.3.4 Mexico Erectile Dysfunction Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Erectile Dysfunction Revenue by Type (2017-2028)

7.2 Europe Erectile Dysfunction Revenue by Application (2017-2028)

7.3 Europe Erectile Dysfunction Market Size by Country

7.3.1 Europe Erectile Dysfunction Revenue by Country (2017-2028)

7.3.2 Germany Erectile Dysfunction Market Size and Forecast (2017-2028)

7.3.3 France Erectile Dysfunction Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Erectile Dysfunction Market Size and Forecast (2017-2028)

7.3.5 Russia Erectile Dysfunction Market Size and Forecast (2017-2028)

7.3.6 Italy Erectile Dysfunction Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Erectile Dysfunction Revenue by Type (2017-2028)

8.2 Asia-Pacific Erectile Dysfunction Revenue by Application (2017-2028)

8.3 Asia-Pacific Erectile Dysfunction Market Size by Region

8.3.1 Asia-Pacific Erectile Dysfunction Revenue by Region (2017-2028)

8.3.2 China Erectile Dysfunction Market Size and Forecast (2017-2028)

8.3.3 Japan Erectile Dysfunction Market Size and Forecast (2017-2028)

8.3.4 South Korea Erectile Dysfunction Market Size and Forecast (2017-2028)

8.3.5 India Erectile Dysfunction Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Erectile Dysfunction Market Size and Forecast (2017-2028)

8.3.7 Australia Erectile Dysfunction Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Erectile Dysfunction Revenue by Type (2017-2028)

9.2 South America Erectile Dysfunction Revenue by Application (2017-2028)

9.3 South America Erectile Dysfunction Market Size by Country

9.3.1 South America Erectile Dysfunction Revenue by Country (2017-2028)

9.3.2 Brazil Erectile Dysfunction Market Size and Forecast (2017-2028)

9.3.3 Argentina Erectile Dysfunction Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Erectile Dysfunction Revenue by Type (2017-2028)

10.2 Middle East & Africa Erectile Dysfunction Revenue by Application (2017-2028)

10.3 Middle East & Africa Erectile Dysfunction Market Size by Country

10.3.1 Middle East & Africa Erectile Dysfunction Revenue by Country (2017-2028)

10.3.2 Turkey Erectile Dysfunction Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Erectile Dysfunction Market Size and Forecast (2017-2028)

10.3.4 UAE Erectile Dysfunction Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Erectile Dysfunction Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Erectile Dysfunction Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Erectile Dysfunction Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Erectile Dysfunction Revenue (USD Million) by Region (2017-2022)

Table 5. Global Erectile Dysfunction Revenue Market Share by Region (2023-2028)

Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 7. Eli Lilly Major Business

Table 8. Eli Lilly Erectile Dysfunction Product and Solutions

Table 9. Eli Lilly Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Pfizer Corporate Information, Head Office, and Major Competitors

Table 11. Pfizer Major Business

Table 12. Pfizer Erectile Dysfunction Product and Solutions

Table 13. Pfizer Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Bayer Corporate Information, Head Office, and Major Competitors

Table 15. Bayer Major Business

Table 16. Bayer Erectile Dysfunction Product and Solutions

Table 17. Bayer Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Boston Scientific Corporate Information, Head Office, and Major Competitors

Table 19. Boston Scientific Major Business

Table 20. Boston Scientific Erectile Dysfunction Product and Solutions

Table 21. Boston Scientific Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Coloplast Corporate Information, Head Office, and Major Competitors

Table 23. Coloplast Major Business

Table 24. Coloplast Erectile Dysfunction Product and Solutions

Table 25. Coloplast Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Apricus Biosciences Corporate Information, Head Office, and Major Competitors

Table 27. Apricus Biosciences Major Business

Table 28. Apricus Biosciences Erectile Dysfunction Product and Solutions

Table 29. Apricus Biosciences Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Cristalia Produtos Quimicos Farmaceuticos Corporate Information, Head Office, and Major Competitors

Table 31. Cristalia Produtos Quimicos Farmaceuticos Major Business

Table 32. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Product and Solutions

Table 33. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Dong-A Socio Corporate Information, Head Office, and Major Competitors

Table 35. Dong-A Socio Major Business

Table 36. Dong-A Socio Erectile Dysfunction Product and Solutions

Table 37. Dong-A Socio Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 39. Endo Pharmaceuticals Major Business

Table 40. Endo Pharmaceuticals Erectile Dysfunction Product and Solutions

Table 41. Endo Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Futura Medical Corporate Information, Head Office, and Major Competitors

Table 43. Futura Medical Major Business

Table 44. Futura Medical Erectile Dysfunction Product and Solutions

Table 45. Futura Medical Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Meda Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 47. Meda Pharmaceuticals Major Business

Table 48. Meda Pharmaceuticals Erectile Dysfunction Product and Solutions

Table 49. Meda Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Promedon Corporate Information, Head Office, and Major Competitors

Table 51. Promedon Major Business

Table 52. Promedon Erectile Dysfunction Product and Solutions

Table 53. Promedon Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. SK Chemical Corporate Information, Head Office, and Major Competitors

Table 55. SK Chemical Major Business

Table 56. SK Chemical Erectile Dysfunction Product and Solutions

Table 57. SK Chemical Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 59. Teva Pharmaceuticals Major Business

Table 60. Teva Pharmaceuticals Erectile Dysfunction Product and Solutions

Table 61. Teva Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Vivus Corporate Information, Head Office, and Major Competitors

Table 63. Vivus Major Business

Table 64. Vivus Erectile Dysfunction Product and Solutions

Table 65. Vivus Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Zephyr Surgical Implants (ZSI) Corporate Information, Head Office, and Major Competitors

Table 67. Zephyr Surgical Implants (ZSI) Major Business

Table 68. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Product and Solutions

Table 69. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Global Erectile Dysfunction Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 71. Global Erectile Dysfunction Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 72. Breakdown of Erectile Dysfunction by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. Erectile Dysfunction Players Head Office, Products and Services Provided

Table 74. Erectile Dysfunction Mergers & Acquisitions in the Past Five Years

Table 75. Erectile Dysfunction New Entrants and Expansion Plans

Table 76. Global Erectile Dysfunction Revenue (USD Million) by Type (2017-2022)

Table 77. Global Erectile Dysfunction Revenue Share by Type (2017-2022)

Table 78. Global Erectile Dysfunction Revenue Forecast by Type (2023-2028)

Table 79. Global Erectile Dysfunction Revenue by Application (2017-2022)

Table 80. Global Erectile Dysfunction Revenue Forecast by Application (2023-2028)

Table 81. North America Erectile Dysfunction Revenue by Type (2017-2022) & (USD Million)

Table 82. North America Erectile Dysfunction Revenue by Type (2023-2028) & (USD Million)

Table 83. North America Erectile Dysfunction Revenue by Application (2017-2022) & (USD Million)

Table 84. North America Erectile Dysfunction Revenue by Application (2023-2028) & (USD Million)

Table 85. North America Erectile Dysfunction Revenue by Country (2017-2022) & (USD Million)

Table 86. North America Erectile Dysfunction Revenue by Country (2023-2028) & (USD Million)

Table 87. Europe Erectile Dysfunction Revenue by Type (2017-2022) & (USD Million)

Table 88. Europe Erectile Dysfunction Revenue by Type (2023-2028) & (USD Million)

Table 89. Europe Erectile Dysfunction Revenue by Application (2017-2022) & (USD Million)

Table 90. Europe Erectile Dysfunction Revenue by Application (2023-2028) & (USD Million)

Table 91. Europe Erectile Dysfunction Revenue by Country (2017-2022) & (USD Million)

Table 92. Europe Erectile Dysfunction Revenue by Country (2023-2028) & (USD Million)

Table 93. Asia-Pacific Erectile Dysfunction Revenue by Type (2017-2022) & (USD Million)

Table 94. Asia-Pacific Erectile Dysfunction Revenue by Type (2023-2028) & (USD Million)

Table 95. Asia-Pacific Erectile Dysfunction Revenue by Application (2017-2022) & (USD Million)

Table 96. Asia-Pacific Erectile Dysfunction Revenue by Application (2023-2028) & (USD Million)

Table 97. Asia-Pacific Erectile Dysfunction Revenue by Region (2017-2022) & (USD Million)

Table 98. Asia-Pacific Erectile Dysfunction Revenue by Region (2023-2028) & (USD Million)

Table 99. South America Erectile Dysfunction Revenue by Type (2017-2022) & (USD Million)

Table 100. South America Erectile Dysfunction Revenue by Type (2023-2028) & (USD Million)

Table 101. South America Erectile Dysfunction Revenue by Application (2017-2022) & (USD Million)

Table 102. South America Erectile Dysfunction Revenue by Application (2023-2028) & (USD Million)

Table 103. South America Erectile Dysfunction Revenue by Country (2017-2022) & (USD Million)

Table 104. South America Erectile Dysfunction Revenue by Country (2023-2028) & (USD Million)

Table 105. Middle East & Africa Erectile Dysfunction Revenue by Type (2017-2022) & (USD Million)

Table 106. Middle East & Africa Erectile Dysfunction Revenue by Type (2023-2028) & (USD Million)

Table 107. Middle East & Africa Erectile Dysfunction Revenue by Application (2017-2022) & (USD Million)

Table 108. Middle East & Africa Erectile Dysfunction Revenue by Application (2023-2028) & (USD Million)

Table 109. Middle East & Africa Erectile Dysfunction Revenue by Country (2017-2022) & (USD Million)

Table 110. Middle East & Africa Erectile Dysfunction Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Erectile Dysfunction Picture

Figure 2. Global Erectile Dysfunction Revenue Market Share by Type in 2021

Figure 3. ED Drugs

Figure 4. ED Devices

Figure 5. Erectile Dysfunction Revenue Market Share by Application in 2021

Figure 6. Congenital Patients Picture

Figure 7. Pathological Patients Picture

Figure 8. Global Erectile Dysfunction Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 9. Global Erectile Dysfunction Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global Erectile Dysfunction Revenue Market Share by Region (2017-2028)

Figure 11. Global Erectile Dysfunction Revenue Market Share by Region in 2021

Figure 12. North America Erectile Dysfunction Revenue (USD Million) and Growth Rate (2017-2028)

Figure 13. Europe Erectile Dysfunction Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Asia-Pacific Erectile Dysfunction Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. South America Erectile Dysfunction Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Middle East and Africa Erectile Dysfunction Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Erectile Dysfunction Market Drivers

Figure 18. Erectile Dysfunction Market Restraints

Figure 19. Erectile Dysfunction Market Trends

Figure 20. Eli Lilly Recent Developments and Future Plans

Figure 21. Pfizer Recent Developments and Future Plans

Figure 22. Bayer Recent Developments and Future Plans

Figure 23. Boston Scientific Recent Developments and Future Plans

Figure 24. Coloplast Recent Developments and Future Plans

Figure 25. Apricus Biosciences Recent Developments and Future Plans

Figure 26. Cristalia Produtos Quimicos Farmaceuticos Recent Developments and Future Plans

Figure 27. Dong-A Socio Recent Developments and Future Plans

Figure 28. Endo Pharmaceuticals Recent Developments and Future Plans

Figure 29. Futura Medical Recent Developments and Future Plans

Figure 30. Meda Pharmaceuticals Recent Developments and Future Plans

Figure 31. Promedon Recent Developments and Future Plans

Figure 32. SK Chemical Recent Developments and Future Plans

Figure 33. Teva Pharmaceuticals Recent Developments and Future Plans

Figure 34. Vivus Recent Developments and Future Plans

Figure 35. Zephyr Surgical Implants (ZSI) Recent Developments and Future Plans

Figure 36. Global Erectile Dysfunction Revenue Share by Players in 2021

Figure 37. Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Erectile Dysfunction Revenue Market Share in 2021

Figure 39. Global Top 10 Players Erectile Dysfunction Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Erectile Dysfunction Revenue Share by Type in 2021

Figure 42. Global Erectile Dysfunction Market Share Forecast by Type (2023-2028)

Figure 43. Global Erectile Dysfunction Revenue Share by Application in 2021

Figure 44. Global Erectile Dysfunction Market Share Forecast by Application (2023-2028)

Figure 45. North America Erectile Dysfunction Sales Market Share by Type (2017-2028)

Figure 46. North America Erectile Dysfunction Sales Market Share by Application (2017-2028)

Figure 47. North America Erectile Dysfunction Revenue Market Share by Country (2017-2028)

Figure 48. United States Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Erectile Dysfunction Sales Market Share by Type (2017-2028)

Figure 52. Europe Erectile Dysfunction Sales Market Share by Application (2017-2028)

Figure 53. Europe Erectile Dysfunction Revenue Market Share by Country (2017-2028)

Figure 54. Germany Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Erectile Dysfunction Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Erectile Dysfunction Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Erectile Dysfunction Revenue Market Share by Region (2017-2028)

Figure 62. China Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Erectile Dysfunction Sales Market Share by Type (2017-2028)

Figure 69. South America Erectile Dysfunction Sales Market Share by Application (2017-2028)

Figure 70. South America Erectile Dysfunction Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Erectile Dysfunction Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Erectile Dysfunction Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Erectile Dysfunction Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Erectile Dysfunction Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source